SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019921
Filing Date
2022-05-12
Accepted
2022-05-12 17:01:16
Documents
49
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-10q_20220331.htm   iXBRL 10-Q 1532512
2 EX-31.1 eldn-ex311_7.htm EX-31.1 11382
3 EX-31.2 eldn-ex312_8.htm EX-31.2 11429
4 EX-32.1 eldn-ex321_9.htm EX-32.1 7505
5 EX-32.2 eldn-ex322_6.htm EX-32.2 7796
  Complete submission text file 0001564590-22-019921.txt   4858866

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eldn-20220331.xsd EX-101.SCH 39410
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eldn-20220331_cal.xml EX-101.CAL 31434
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eldn-20220331_def.xml EX-101.DEF 110869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eldn-20220331_lab.xml EX-101.LAB 259567
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eldn-20220331_pre.xml EX-101.PRE 196997
43 EXTRACTED XBRL INSTANCE DOCUMENT eldn-10q_20220331_htm.xml XML 728444
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 22918803
SIC: 2834 Pharmaceutical Preparations